MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.archger.2026.106305

Медицинская библиотека · Archives of gerontology and geriatrics · 2026

Development and validation of a GDF-15-albumin-CRP score for predicting Cachexia in Asian patients with decompensated cirrhosis.

Yao Shuangzhe, Peng Binbin, Ren Lingyu, Yang Ziyi, Jiang Kui, Sun Chao

СтатьяВалидационное исследованиеПеревод в очереди

Аннотация

BACKGROUND & AIMS: Cachexia is prevalent and prognostically adverse in decompensated cirrhosis. Diagnosis is challenging, especially in Asian populations, due to limitations of current criteria and scoring systems. This study aimed to develop and validate a biomarker-based model for predicting cachexia defined by the Asian Working Group for Cachexia (AWGC) in cirrhotic patients.

METHODS

In this retrospective cohort study, 420 patients with decompensated cirrhosis were enrolled (295 in the training cohort, 125 in the external validation cohort). Cachexia was diagnosed according to AWGC criteria. LASSO regression selected predictive serum biomarkers. A nomogram-derived GDF-15-Albumin-CRP score was constructed, and its performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration, and decision curve analysis (DCA).

RESULTS

In the training cohort, 158 patients (53.56%) had cachexia. LASSO regression identified serum growth differentiation factor-15 (GDF-15), albumin, and C-reactive protein (CRP) as the strongest predictors. The resulting GDF-15-Albumin-CRP score achieved an AUC of 0.736 (95% CI: 0.680-0.792) for cachexia prediction, significantly outperforming Child-Turcotte-Pugh (CTP), Model for End-Stage Liver Disease (MELD), and MELD-Na scores (all P < 0.05). DCA demonstrated clinical net benefit across a wide range of threshold probabilities. The score exhibited a strong risk gradient for cachexia (adjusted OR for the high- vs. low-risk group: 7.58; 95% CI: 2.68-21.46). External validation confirmed its performance (AUC = 0.723, 95% CI: 0.630-0.810).

CONCLUSIONS

The GDF-15-Albumin-CRP score is a validated and clinically feasible tool predicting AWGC-defined cachexia in Asian cirrhotic patients, superior to traditional severity scores and potentially enabling earlier targeted intervention.

Для цитирования: Yao Shuangzhe, Peng Binbin, Ren Lingyu, Yang Ziyi, Jiang Kui, Sun Chao. Development and validation of a GDF-15-albumin-CRP score for predicting Cachexia in Asian patients with decompensated cirrhosis.. Archives of gerontology and geriatrics. 2026. DOI: 10.1016/j.archger.2026.106305.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.